QT
ATRA icon

Quantbot Technologies’s Atara Biotherapeutics ATRA Stock Holding History

Quantbot Technologies’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-156
Closed -$6.28K – 1529
2023
Q2 		$6.28K Buy
+156
New +$8.82K ﹤0.01% 1482
2022
Q3 		– Sell
-546
Closed -$106K – 1585
2022
Q2 		$106K Buy
+546
New +$89.1K 0.01% 1127
2021
Q3 		– Sell
-70
Closed -$27K – 1514
2021
Q2 		$27K Sell
70
-870
-93% -$310K ﹤0.01% 1180
2021
Q1 		$337K Buy
940
+867
+1,188% +$383K 0.03% 596
2020
Q4 		$35K Sell
73
-103
-59% -$47.5K ﹤0.01% 925
2020
Q3 		$56K Buy
+176
New +$59.9K 0.01% 832
2020
Q2 		– Sell
-3
Closed – – 1122
2020
Q1 		$0 Buy
+3
New +$952 ﹤0.01% 907
2019
Q4 		– Sell
-20
Closed -$7K – 1212
2019
Q3 		$7K Sell
20
-144
-88% -$53.7K ﹤0.01% 1187
2019
Q2 		$82K Buy
+164
New +$116K 0.01% 794
2018
Q2 		– Sell
-23
Closed -$22K – 1186
2018
Q1 		$22K Buy
+23
New +$21K ﹤0.01% 1057
2015
Q4 		– Sell
-124
Closed -$97K – 1065
2015
Q3 		$97K Buy
124
+80
+182% +$97.6K 0.02% 770
2015
Q2 		$58K Buy
+44
New +$50.5K 0.01% 788

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantbot Technologies's ATRA Position: Q3 2023 in Review

Quantbot Technologies sold out of Atara Biotherapeutics (ATRA) in Q3 2023, closing a stake of 156 shares — an estimated $6.28K sold.

Quantbot Technologies first reported a position in ATRA in Q2 2015 and held it in 12 quarters. The position peaked at $337K in Q1 2021. 109 funds tracked by Wall St. Rank hold ATRA as of Q3 2023.

  • Quantbot Technologies reported no remaining Atara Biotherapeutics position as of Q3 2023 after selling out during the quarter.
  • Quantbot Technologies sold 156 Atara Biotherapeutics shares in Q3 2023, an estimated $6.28K.
  • Quantbot Technologies first reported a position in Atara Biotherapeutics in Q2 2015 and held it in 12 quarters.
  • Quantbot Technologies's Atara Biotherapeutics position peaked at $337K in Q1 2021.
  • 109 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2023.

Based on Quantbot Technologies's 13F filing for Q3 2023, filed 7 Nov 2023.